Scientific studies show that, along with normal aging, excess arachidonic acid ignites a biochemical cascade that increases levels of the 5-lipoxygenase (5-LOX) enzyme, which can induce undesirable effects in cells throughout the body. This cascade culminates in the excess accumulation of leukotriene B4, a proinflammatory compound that attacks the joints, the arterial wall, and other tissues.

In India, extracts from the Boswellia plant have been used for centuries as anti-inflammatory agents. Recent human studies have confirmed that a specific Boswellia extract known as AKBA (3-O-acetyl-11 keto-ß-boswellic acid) selectively inhibits 5-LOX. Unlike other boswellic acids that only partially inhibit 5-LOX, AKBA binds directly to 5-LOX, effectively suppressing its pro-inflammatory activity.

Directions: Take one capsule daily with or without food, or as recommended by a healthcare practitioner.

Ingredients: 1 capsule supplies: 5-LOXIN® [std. for acetyl-11- keto-ß-boswellic acid (AKBA) minimum 30% on dried basis (22.5 mg)] 75 mg.
Other Ingredients: dicalcium phosphate, vegetable capsule, rice flour, magnesium stearate, silica.
Contains rice. This product contains NO milk, egg, fish, peanuts, crustacean shellfish (lobster, crab, shrimp), soybeans, tree nuts, wheat, yeast, gluten, or corn. Contains NO sugar, and no artificial sweeteners, flavors, or preservatives.
5-LOXIN is a registered trademark of P.L. Thomas & Co., Inc. U.S. patents pending.